Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Inhibrx, Inc. (INBX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights",
"14 2821 40 100 60 80 20 0 0 7"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/25/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/08/2023 8-K Quarterly results
Docs: "Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights"
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 8-K Quarterly results
04/13/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/06/2023 8-K Quarterly results
Docs: "Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results",
"HD 1H 2024 INBRX-109 INBRX-105"
03/06/2023 10-K Annual Report for the period ended December 31, 2022
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 8.9% stake in INHIBRX, INC.
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 7.6% stake in Inhibrx, Inc.
02/14/2023 SC 13G/A VIKING GLOBAL INVESTORS LP reports a 15.2% stake in Inhibrx, Inc.
02/08/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G BlackRock Inc. reports a 5.5% stake in Inhibrx, Inc.
11/16/2022 8-K Quarterly results
11/07/2022 8-K Quarterly results
11/07/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/26/2022 8-K Quarterly results
10/17/2022 SC 13G RA CAPITAL MANAGEMENT, L.P. reports a 8.2% stake in INHIBRX, INC.
10/04/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT",
"80 60 0 40 20",
"Inhibrx Announces Opportunity for Accelerated Approval Pathway on Functional AAT Serum Levels for INBRX-101 in AATD and Announces Bronchoalveolar Lavage Fluid Detection Results from the Phase 1study"
08/15/2022 8-K Quarterly results
08/10/2022 8-K Quarterly results
08/08/2022 8-K Quarterly results
08/08/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/18/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
06/30/2022 8-K Quarterly results
06/16/2022 8-K Quarterly results
05/25/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/09/2022 8-K Quarterly results
05/09/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/25/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Inhibrx Announces Formation of Scientific Advisory Board for INBRX-101"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy